{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T00:14:55Z","timestamp":1794788095742,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"national natural fundation of china","award":["82203167"],"award-info":[{"award-number":["82203167"]}]},{"name":"natural science fundation project of gansu province","award":["21JR7RA419"],"award-info":[{"award-number":["21JR7RA419"]}]},{"name":"natural science fundation project of gansu province","award":["21JR11RA110"],"award-info":[{"award-number":["21JR11RA110"]}]},{"name":"the cuiying scientific and technological innovation program of lanzhou university second hospital","award":["CY2022-MS-A09"],"award-info":[{"award-number":["CY2022-MS-A09"]}]},{"name":"Project of the Affiliated Hospital of Inner Mongolia Medical University-The Open Fund of Key Laboratory","award":["2023NYFYSYS008"],"award-info":[{"award-number":["2023NYFYSYS008"]}]},{"name":"traditional chinese medicine scientific research project of gansu province","award":["GZKP-2020-29"],"award-info":[{"award-number":["GZKP-2020-29"]}]},{"name":"cuiying scientific training program for undergraduates of lanzhou university second hospital","award":["CYXZ2022-27"],"award-info":[{"award-number":["CYXZ2022-27"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sanguinarine chloride (S.C) is a benzophenanthrine alkaloid derived from the root of sanguinaria canadensis and other poppy-fumaria species. Studies have reported that S.C exhibits antioxidant, anti-inflammatory, proapoptotic, and growth inhibitory effects, which contribute to its anti-cancer properties. Recent studies suggested that the antitumor effect of S.C through inducing ferroptosis in some cancers. Nevertheless, the precise mechanism underlying the regulation of ferroptosis by S.C remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A small molecule library was constructed based on FDA and CFDA approved small molecular drugs. CCK-8 assay was applied to evaluate the effects of the small molecule compound on tumor cell viability. Prostate cancer cells were treated with S.C and then the cell viability and migration ability were assessed using CCK8, colony formation and wound healing assay. Reactive oxygen species (ROS) and iron accumulation were quantified through flow cytometry analysis. The levels of malondialdehyde (MDA) and total glutathione (GSH) were measured using commercially available kits. RNA-seq analysis was performed to identify differentially expressed genes (DEGs) among the treatment groups. Western blotting and qPCR were utilized to investigate the expression of relevant proteins and genes. In vivo experiments employed a xenograft mice model to evaluate the anti-cancer efficacy of S.C.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study demonstrated that S.C effectively inhibited the viability of various prostate cancer cells. Notably, S.C exhibited the ability to enhance the cytotoxicity of docetaxel in DU145 cells. We found that S.C-induced cell death partially relied on the induction of ferroptosis, which was mediated through up-regulation of HMOX1 protein. Additionally, our investigation revealed that S.C treatment decreased the stability of BACH1 protein, which contributed to HMOX1expression. We further identified that S.C-induced ROS caused BACH1 instability by suppressing USP47expression. Moreover, In DU145 xenograft model, we found S.C significantly inhibited prostate cancer growth, highlighting its potential as a therapeutic strategy. Collectively, these findings provide evidence that S.C could induce regulated cell death (RCD) in prostate cancer cells and effectively inhibit tumor growth via triggering ferroptosis. This study provides evidence that S.C effectively suppresses tumor progression and induces ferroptosis in prostate cancer cells by targeting ROS\/USP47\/BACH1\/HMOX1 axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides evidence that S.C effectively suppresses tumor progression and induces ferroptosis in prostate cancer cells by targeting the ROS\/USP47\/BACH1\/HMOX1 axis. These findings offer novel insights into the underlying mechanism by which S.C inhibits the progression of prostate cancer. Furthermore, leveraging the potential of S.C in targeting ferroptosis may present a new therapeutic opportunity for prostate cancer. This study found that S.C induces ferroptosis by targeting the ROS\/USP47\/BACH1\/HMOX1 axis in prostate cancer cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-024-00881-6","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:07:22Z","timestamp":1704794842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Sanguinarine chloride induces ferroptosis by regulating ROS\/BACH1\/HMOX1 signaling pathway in prostate cancer"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9254-5339","authenticated-orcid":false,"given":"Shanhui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beitang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"issue":"1","key":"881_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"881_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77(1):38\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.005.","journal-title":"Eur Urol"},{"key":"881_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2\u20133","key":"881_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10555-013-9474-0","volume":"33","author":"Z Culig","year":"2014","unstructured":"Culig Z, Santer FR. Androgen receptor signaling in prostate cancer. Cancer Metastasis Rev. 2014;33(2\u20133):413\u201327. https:\/\/doi.org\/10.1007\/s10555-013-9474-0.","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"881_CR5","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","volume":"65","author":"M Kirby","year":"2011","unstructured":"Kirby M, Hirst C, Crawford ED. Characterising the castration-resistant prostate cancer population: a systematic review. Int J Clin Pract. 2011;65(11):1180\u201392. https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02799.x.","journal-title":"Int J Clin Pract"},{"issue":"14","key":"881_CR6","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003.","journal-title":"Cell"},{"issue":"5","key":"881_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"21","key":"881_CR8","doi-asserted-by":"publisher","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","volume":"30","author":"D Tang","year":"2020","unstructured":"Tang D, Kroemer G. Ferroptosis. Current Biol CB. 2020;30(21):R1292-r1297. https:\/\/doi.org\/10.1016\/j.cub.2020.09.068.","journal-title":"Current Biol CB"},{"issue":"1","key":"881_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y.","journal-title":"Mol Cancer"},{"issue":"11","key":"881_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nnano.2016.164","volume":"11","author":"SE Kim","year":"2016","unstructured":"Kim SE, Zhang L, Ma K, Riegman M, Chen F, Ingold I, et al. Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat Nanotechnol. 2016;11(11):977\u201385. https:\/\/doi.org\/10.1038\/nnano.2016.164.","journal-title":"Nat Nanotechnol"},{"key":"881_CR11","doi-asserted-by":"publisher","first-page":"154102","DOI":"10.1016\/j.phymed.2022.154102","volume":"101","author":"Y Liu","year":"2022","unstructured":"Liu Y, Liu X, Wang H, Ding P, Wang C. Agrimonolide inhibits cancer progression and induces ferroptosis and apoptosis by targeting SCD1 in ovarian cancer cells. Phytomed Int J Phytother Phytopharmacol. 2022;101:154102. https:\/\/doi.org\/10.1016\/j.phymed.2022.154102.","journal-title":"Phytomed Int J Phytother Phytopharmacol"},{"key":"881_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2022.01.009","volume":"180","author":"W Zhang","year":"2022","unstructured":"Zhang W, Jiang B, Liu Y, Xu L, Wan M. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4. Free Radical Biol Med. 2022;180:75\u201384. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.01.009.","journal-title":"Free Radical Biol Med"},{"key":"881_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081795","author":"A Alakkal","year":"2022","unstructured":"Alakkal A, Thayyullathil F, Pallichankandy S, Subburayan K, Cheratta AR, Galadari S. Sanguinarine Induces H(2)O(2)-dependent apoptosis and ferroptosis in human cervical cancer. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10081795.","journal-title":"Biomedicines"},{"key":"881_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25051229","author":"AQ Khan","year":"2020","unstructured":"Khan AQ, Mohamed EAN, Hakeem I, Nazeer A, Kuttikrishnan S, Prabhu KS, et al. Sanguinarine induces apoptosis in papillary thyroid cancer cells via generation of reactive oxygen species. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25051229.","journal-title":"Molecules"},{"key":"881_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158329","author":"SS Messeha","year":"2022","unstructured":"Messeha SS, Zarmouh NO, Antonie L, Soliman KFA. Sanguinarine inhibition of TNF-\u03b1-induced CCL2, IKBKE\/NF-\u03baB\/ERK1\/2 signaling pathway, and cell migration in human triple-negative breast cancer cells. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158329.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"881_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tiv.2008.12.013","volume":"23","author":"BC Jang","year":"2009","unstructured":"Jang BC, Park JG, Song DK, Baek WK, Yoo SK, Jung KH, et al. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Toxicol Vitro Int J Publ Assoc BIBRA. 2009;23(2):281\u20137. https:\/\/doi.org\/10.1016\/j.tiv.2008.12.013.","journal-title":"Toxicol Vitro Int J Publ Assoc BIBRA"},{"key":"881_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fonc.2019.00285","volume":"9","author":"S Akhtar","year":"2019","unstructured":"Akhtar S, Achkar IW, Siveen KS, Kuttikrishnan S, Prabhu KS, Khan AQ, et al. Sanguinarine induces apoptosis pathway in multiple myeloma cell lines via inhibition of the JaK2\/STAT3 signaling. Frontiersoncol. 2019;9:285. https:\/\/doi.org\/10.3389\/fonc.2019.00285.","journal-title":"Frontiersoncol"},{"issue":"4","key":"881_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000149719","volume":"54","author":"WY Choi","year":"2008","unstructured":"Choi WY, Kim GY, Lee WH, Choi YH. Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy. 2008;54(4):279\u201387. https:\/\/doi.org\/10.1159\/000149719.","journal-title":"Chemotherapy"},{"key":"881_CR19","doi-asserted-by":"publisher","first-page":"153500","DOI":"10.1016\/j.phymed.2021.153500","volume":"84","author":"MA Ghauri","year":"2021","unstructured":"Ghauri MA, Su Q, Ullah A, Wang J, Sarwar A, Wu Q, et al. Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer. Phytomed Int J Phytother Phytopharmacol. 2021;84:153500. https:\/\/doi.org\/10.1016\/j.phymed.2021.153500.","journal-title":"Phytomed Int J Phytother Phytopharmacol"},{"issue":"2","key":"881_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/cbdd.13621","volume":"95","author":"R Sarkhosh-Inanlou","year":"2020","unstructured":"Sarkhosh-Inanlou R, Molaparast M, Mohammadzadeh A, Shafiei-Irannejad V. Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells. Chem Biol Drug Des. 2020;95(2):215\u201323. https:\/\/doi.org\/10.1111\/cbdd.13621.","journal-title":"Chem Biol Drug Des"},{"issue":"7","key":"881_CR21","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA. 2019;116(7):2672\u201380. https:\/\/doi.org\/10.1073\/pnas.1821022116.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"881_CR22","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/JCI99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Investig. 2018;128(8):3341\u201355. https:\/\/doi.org\/10.1172\/JCI99032.","journal-title":"J Clin Investig"},{"issue":"1","key":"881_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12894-022-01020-9","volume":"22","author":"Y Tao","year":"2022","unstructured":"Tao Y, Liu S, Lu J, Fu S, Li L, Zhang J, et al. FOXO3a-ROS pathway is involved in androgen-induced proliferation of prostate cancer cell. BMC Urol. 2022;22(1):70. https:\/\/doi.org\/10.1186\/s12894-022-01020-9.","journal-title":"BMC Urol"},{"issue":"1","key":"881_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.20517\/cdr.2021.105","volume":"5","author":"B Biersack","year":"2022","unstructured":"Biersack B, Nitzsche B, H\u00f6pfner M. HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer. Cancer Drug Resistance. 2022;5(1):64\u201379. https:\/\/doi.org\/10.20517\/cdr.2021.105.","journal-title":"Cancer Drug Resistance"},{"issue":"3","key":"881_CR25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/0008-5472.can-08-2216","volume":"69","author":"DS Welsbie","year":"2009","unstructured":"Welsbie DS, Xu J, Chen Y, Borsu L, Scher HI, Rosen N, et al. Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer. Can Res. 2009;69(3):958\u201366. https:\/\/doi.org\/10.1158\/0008-5472.can-08-2216.","journal-title":"Can Res"},{"key":"881_CR26","doi-asserted-by":"publisher","first-page":"682762","DOI":"10.3389\/fonc.2021.682762","volume":"11","author":"R Xu","year":"2021","unstructured":"Xu R, Luo X, Ye X, Li H, Liu H, Du Q, et al. SIRT1\/PGC-1\u03b1\/PPAR-\u03b3 correlate with hypoxia-induced chemoresistance in non-small cell lung cancer. Front oncol. 2021;11:682762. https:\/\/doi.org\/10.3389\/fonc.2021.682762.","journal-title":"Front oncol"},{"issue":"6","key":"881_CR27","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/med.21574","volume":"39","author":"Q Wu","year":"2019","unstructured":"Wu Q, Wu W, Fu B, Shi L, Wang X, Kuca K. JNK signaling in cancer cell survival. Med Res Rev. 2019;39(6):2082\u2013104. https:\/\/doi.org\/10.1002\/med.21574.","journal-title":"Med Res Rev"},{"issue":"5","key":"881_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tcb.2021.01.010","volume":"31","author":"M Bury","year":"2021","unstructured":"Bury M, Le Calv\u00e9 B, Ferbeyre G, Blank V, Lessard F. New insights into CDK regulators: novel opportunities for cancer therapy. Trends Cell Biol. 2021;31(5):331\u201344. https:\/\/doi.org\/10.1016\/j.tcb.2021.01.010.","journal-title":"Trends Cell Biol"},{"key":"881_CR29","doi-asserted-by":"publisher","first-page":"586578","DOI":"10.3389\/fcell.2020.586578","volume":"8","author":"F Kuang","year":"2020","unstructured":"Kuang F, Liu J, Tang D, Kang R. Oxidative damage and antioxidant defense in ferroptosis. Front Cell Develop Biol. 2020;8:586578. https:\/\/doi.org\/10.3389\/fcell.2020.586578.","journal-title":"Front Cell Develop Biol"},{"issue":"21","key":"881_CR30","doi-asserted-by":"publisher","first-page":"7074","DOI":"10.1093\/nar\/gkm638","volume":"35","author":"JF Reichard","year":"2007","unstructured":"Reichard JF, Motz GT, Puga A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucl Acids Res. 2007;35(21):7074\u201386. https:\/\/doi.org\/10.1093\/nar\/gkm638.","journal-title":"Nucl Acids Res"},{"key":"881_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.pharmtox.010909.105600","volume":"50","author":"R Gozzelino","year":"2010","unstructured":"Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Ann Rev Pharmacol Toxicol. 2010;50:323\u201354. https:\/\/doi.org\/10.1146\/annurev.pharmtox.010909.105600.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"881_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.abb.2014.09.005","volume":"564","author":"Y Naito","year":"2014","unstructured":"Naito Y, Takagi T, Higashimura Y. Heme oxygenase-1 and anti-inflammatory M2 macrophages. Archiv Biochemist Biophys. 2014;564:83\u20138. https:\/\/doi.org\/10.1016\/j.abb.2014.09.005.","journal-title":"Archiv Biochemist Biophys"},{"issue":"11","key":"881_CR33","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.7150\/ijbs.59404","volume":"17","author":"R Wei","year":"2021","unstructured":"Wei R, Zhao Y, Wang J, Yang X, Li S, Wang Y, et al. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci. 2021;17(11):2703\u201317. https:\/\/doi.org\/10.7150\/ijbs.59404.","journal-title":"Int J Biol Sci"},{"issue":"Pt B","key":"881_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.freeradbiomed.2015.03.030","volume":"88","author":"K Zimmermann","year":"2015","unstructured":"Zimmermann K, Baldinger J, Mayerhofer B, Atanasov AG, Dirsch VM, Heiss EH. Activated AMPK boosts the Nrf2\/HO-1 signaling axis\u2013A role for the unfolded protein response. Free Radical Biol Med. 2015;88(Pt B):417\u201326. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.03.030.","journal-title":"Free Radical Biol Med"},{"issue":"3","key":"881_CR35","doi-asserted-by":"publisher","first-page":"F464","DOI":"10.1152\/ajprenal.00501.2020","volume":"320","author":"HR Potteti","year":"2021","unstructured":"Potteti HR, Noone PM, Tamatam CR, Ankireddy A, Noel S, Rabb H, et al. Nrf2 mediates hypoxia-inducible HIF1\u03b1 activation in kidney tubular epithelial cells. Am J Physiol Renal Physiol. 2021;320(3):F464-f474. https:\/\/doi.org\/10.1152\/ajprenal.00501.2020.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"881_CR36","first-page":"91","volume":"12","author":"J Peng","year":"2022","unstructured":"Peng J, Li W, Tan N, Lai X, Jiang W, Chen G. USP47 stabilizes BACH1 to promote the Warburg effect and non-small cell lung cancer development via stimulating Hk2 and Gapdh transcription. Am J Cancer Res. 2022;12(1):91\u2013107.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"881_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.eururo.2018.03.028","volume":"75","author":"P Nuhn","year":"2019","unstructured":"Nuhn P, De Bono JS, Fizazi K, Freedland SJ, Grilli M, Kantoff PW, et al. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology. Eur Urol. 2019;75(1):88\u201399. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.028.","journal-title":"Eur Urol"},{"issue":"5","key":"881_CR38","first-page":"1567","volume":"148","author":"M Krajewska","year":"1996","unstructured":"Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol. 1996;148(5):1567\u201376.","journal-title":"Am J Pathol"},{"issue":"8","key":"881_CR39","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.18632\/oncotarget.3368","volume":"6","author":"FR Santer","year":"2015","unstructured":"Santer FR, Erb HH, Oh SJ, Handle F, Feiersinger GE, Luef B, et al. Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy. Oncotarget. 2015;6(8):6105\u201322. https:\/\/doi.org\/10.18632\/oncotarget.3368.","journal-title":"Oncotarget"},{"issue":"12","key":"881_CR40","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/sj.onc.1207326","volume":"23","author":"H Huang","year":"2004","unstructured":"Huang H, Zegarra-Moro OL, Benson D, Tindall DJ. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells. Oncogene. 2004;23(12):2161\u201376. https:\/\/doi.org\/10.1038\/sj.onc.1207326.","journal-title":"Oncogene"},{"key":"881_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1038225","author":"X Qi","year":"2022","unstructured":"Qi X, Wan Z, Jiang B, Ouyang Y, Feng W, Zhu H, et al. Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer. Frontiers Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1038225.","journal-title":"Frontiers Immunol"},{"issue":"6","key":"881_CR42","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/0008-5472.can-20-3477","volume":"81","author":"A Ghoochani","year":"2021","unstructured":"Ghoochani A, Hsu EC, Aslan M, Rice MA, Nguyen HM, Brooks JD, et al. Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer. Can Res. 2021;81(6):1583\u201394. https:\/\/doi.org\/10.1158\/0008-5472.can-20-3477.","journal-title":"Can Res"},{"issue":"24","key":"881_CR43","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.2174\/0929867329666220111120924","volume":"29","author":"N Zaffaroni","year":"2022","unstructured":"Zaffaroni N, Beretta GL. Ferroptosis inducers for prostate cancer therapy. Curr Med Chem. 2022;29(24):4185\u2013201. https:\/\/doi.org\/10.2174\/0929867329666220111120924.","journal-title":"Curr Med Chem"},{"issue":"6","key":"881_CR44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00280-003-0609-9","volume":"51","author":"E Debiton","year":"2003","unstructured":"Debiton E, Madelmont JC, Legault J, Barthomeuf C. Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion. Cancer Chemother Pharmacol. 2003;51(6):474\u201382. https:\/\/doi.org\/10.1007\/s00280-003-0609-9.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"881_CR45","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/1381612828666220217124542","volume":"28","author":"R Xu","year":"2022","unstructured":"Xu R, Wu J, Luo Y, Wang Y, Tian J, Teng W, et al. Sanguinarine represses the growth and metastasis of non-small cell lung cancer by facilitating ferroptosis. Curr Pharm Des. 2022;28(9):760\u20138. https:\/\/doi.org\/10.2174\/1381612828666220217124542.","journal-title":"Curr Pharm Des"},{"key":"881_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","volume":"416","author":"LC Chang","year":"2018","unstructured":"Chang LC, Chiang SK, Chen SE, Yu YL, Chou RH, Chang WC. Heme oxygenase-1 mediates BAY 11\u20137085 induced ferroptosis. Cancer Lett. 2018;416:124\u201337. https:\/\/doi.org\/10.1016\/j.canlet.2017.12.025.","journal-title":"Cancer Lett"},{"issue":"8","key":"881_CR47","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jacbts.2022.03.012","volume":"7","author":"HD Miyamoto","year":"2022","unstructured":"Miyamoto HD, Ikeda M, Ide T, Tadokoro T, Furusawa S, Abe K, et al. Iron overload via heme degradation in the endoplasmic reticulum triggers ferroptosis in myocardial ischemia-reperfusion injury. JACC Basic Transl Sci. 2022;7(8):800\u201319. https:\/\/doi.org\/10.1016\/j.jacbts.2022.03.012.","journal-title":"JACC Basic Transl Sci"},{"issue":"11","key":"881_CR48","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-019-2064-5","volume":"10","author":"E Park","year":"2019","unstructured":"Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10(11):822. https:\/\/doi.org\/10.1038\/s41419-019-2064-5.","journal-title":"Cell Death Dis"},{"key":"881_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5080843","author":"LJ Su","year":"2019","unstructured":"Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxidative Med Cellular Longevity. 2019. https:\/\/doi.org\/10.1155\/2019\/5080843.","journal-title":"Oxidative Med Cellular Longevity"},{"issue":"8","key":"881_CR50","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1002\/1878-0261.12936","volume":"15","author":"M Liu","year":"2021","unstructured":"Liu M, Fan Y, Li D, Han B, Meng Y, Chen F, et al. Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Mol Oncol. 2021;15(8):2084\u2013105. https:\/\/doi.org\/10.1002\/1878-0261.12936.","journal-title":"Mol Oncol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-024-00881-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-024-00881-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-024-00881-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:11:00Z","timestamp":1704795060000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-024-00881-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1186\/s13020-024-00881-6","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this study, all animal experiment and procedures have been approved and performed in accordance with the Animal Care Welfare Committee of Lanzhou University Second Hospital Ethics approval and consent to participate (D2022-324).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}